BCKDK and maple syrup urine disease: Combining the evidence gained from molecular modeling with the absence of metabolic decompensation in our patients and several adult family members, despite encountering stressors typically problematic in classic MSUD, we suggest that heterozygous gain-of-function variants in <i>BCKDK</i> may represent a novel biochemical phenotype of MSUD with a benign clinical course.